Tag Archives: AMPA

Probably the most well-known type of nootropics are the cholinergic supplements, especially the racetam family. Cholinergics aren’t the only class of mechanism of action for nootropics by a long shot. Most always, nootropics affect the functioning of one or more neurotransmitter systems or specific subreceptors. AMPAkines are in some cases some of the most potent of all the different > View article

Aniracetam was the second racetam developed by Dr. Corneliu Giurgea after piracetam. Piracetam, which began it’s life as a cyclic derivative of the primary inhibitory neurotransmitter GABA was modified in the 70’s to create the related racetam, aniracetam. Oddly enough, there are studies that may suggest that aniracetam itself may not

> View article

A GABA derivative with multiple actions

Piracetam is a member of a group of nootropic racetams called the “primary racetams” which includes: piracetam, aniracetam and oxiracetam. Dr. Corneliu Giurgea began developing the racetams in the 1970‘s in Belgium, but his first entry into the field of nootropic research was piracetam. Incidentally, Dr.

> View article